Epidemiologic and Clinical Features of Mpox in Adults Aged >50 Years — United States, May 2022–May 2023
MMWR. Morbidity and Mortality Weekly Report · 18.08.2023 · 72 (33) · 893-896
DOI: 10.15585/mmwr.mm7233a3 ↗Kurz gefasst
Fachartikel in der Zeitschrift MMWR. Morbidity and Mortality Weekly Report, online erschienen am 18.08.2023. Verfasst von Patrick C Eustaquio und 3 weiteren Autor:innen. Hauptthemen laut MEDLINE: Mpox, Monkeypox. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
During May 2022-May 2023, approximately 30,000 mpox cases were reported in the United States, predominantly among young adult men. Persons aged >50 years might experience more severe mpox disease because of a higher prevalence of comorbidities. Conversely, they could have residual protection from childhood smallpox vaccination against monkeypox virus infection and severe mpox, as has been suggested by investigation of some previous mpox outbreaks. To examine the characteristics of mpox cases among adults aged >50 years, analysts compared mpox epidemiology and clinical outcomes among all adults aged ≥18 years, by age group. Further, outcomes were compared among adults aged >50 years by JYNNEOS vaccination status. During May 10, 2022-May 17, 2023, among 29,984 adults with probable or confirmed mpox reported to CDC, 2,909 (9.7%) were aged >50 years, 96.3% of whom were cisgender men. Compared with adults aged 18-50 years, adults aged >50 years had higher prevalences of immunocompromising conditions (p 50 years, 27.6% had received JYNNEOS vaccination; this group had lower prevalences of constitutional symptoms (p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Zitieren
APA
Eustaquio, P. C., Salmon-Trejo, L. A. T., McGuire, L. C., & Ellington, S. R. (2023). Epidemiologic and Clinical Features of Mpox in Adults Aged >50 Years — United States, May 2022–May 2023. MMWR. Morbidity and Mortality Weekly Report, 72(33), 893-896. https://doi.org/10.15585/mmwr.mm7233a3
Vancouver
Eustaquio PC, Salmon-Trejo LAT, McGuire LC, Ellington SR. Epidemiologic and Clinical Features of Mpox in Adults Aged >50 Years — United States, May 2022–May 2023. MMWR. Morbidity and Mortality Weekly Report. 2023;72(33):893-896. doi:10.15585/mmwr.mm7233a3
BibTeX
@article{Eustaquio2023,
author = {Eustaquio, Patrick C and Salmon-Trejo, LaTweika A T and McGuire, Lisa C and Ellington, Sascha R},
title = {Epidemiologic and Clinical Features of Mpox in Adults Aged >50 Years — United States, May 2022–May 2023},
journal = {MMWR. Morbidity and Mortality Weekly Report},
year = {2023},
volume = {72},
number = {33},
pages = {893--896},
doi = {10.15585/mmwr.mm7233a3}
}
EUVIMED